| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aceragen, Inc. | Director | Warrants | 830,294 | 17 Jan 2023 | NovaQuest Co-Investment Fund XV, L.P. | ||
| IDERA PHARMACEUTICALS, INC. | Director | Series Z Preferred Stock | 14,115 | 28 Sep 2022 | NovaQuest Co-Investment Fund XV, L.P. | ||
| IDERA PHARMACEUTICALS, INC. | Director | Series X Preferred Stock | 5 | 28 Sep 2022 | NovaQuest Co-Investment Fund XV, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465923005136-wooten-ronald-j-2023-01-17 | Aceragen, Inc. | 17 Jan 2023 | 2 | $0 | 4 | Director | 19 Jan 2023, 20:47 |
| /report/000110465922104798-wooten-ronald-j-2022-09-28 | IDERA PHARMACEUTICALS, INC. | 28 Sep 2022 | 4 | $0 | 4 | Director | 30 Sep 2022, 21:50 |
| /report/000110465922104792-wooten-ronald-j-2022-09-28 | IDERA PHARMACEUTICALS, INC. | 28 Sep 2022 | 0 | $0 | 3 | Director | 30 Sep 2022, 21:46 |